» Articles » PMID: 35584837

Radiation-induced Coronary Artery Disease: a Difficult Clinical Conundrum

Overview
Journal Clin Med (Lond)
Specialty General Medicine
Date 2022 May 18
PMID 35584837
Authors
Affiliations
Soon will be listed here.
Abstract

Accelerated coronary artery disease seen following radiation exposure is termed 'radiation-induced coronary artery disease' (RICAD) and results from both the direct and indirect effects of radiation exposure. Long-term data are available from survivors of nuclear explosions and accidents, nuclear workers as well as from radiotherapy patients. The last group is, by far, the biggest cause of RICAD presentation.The incidence of RICAD continues to increase as cancer survival rates improve and it is now the second most common cause of morbidity and mortality in patients treated with radiotherapy for breast cancer, Hodgkin's lymphoma and other mediastinal malignancies. RICAD will frequently present atypically or even asymptomatically with a latency period of at least 10 years after radiotherapy treatment. An awareness of RICAD, as a long-term complication of radiotherapy, is therefore essential for the cardiologist, oncologist and general medical physician alike.Prior cardiac risk factors, a higher radiation dose and a younger age at exposure seem to increase a patient's risk ratio of developing RICAD. Significant radiation exposure, therefore, requires a low threshold for screening for early diagnosis and timely intervention.

Citing Articles

Screening for coronary artery disease among cancer survivors: rationale and design of the REDEEM-CAD study.

Soh C, Smith J, Shrestha S, Nolan M, Wong J, Nerlekar N Cardiooncology. 2025; 11(1):10.

PMID: 39905553 PMC: 11792345. DOI: 10.1186/s40959-025-00308-7.


Navigating the Complexities of Radiation Injuries: Therapeutic Principles and Reconstructive Strategies.

Grosu-Bularda A, Lita F, Hodea F, Bordeanu-Diaconescu E, Cretu A, Dumitru C J Pers Med. 2024; 14(11).

PMID: 39590592 PMC: 11595796. DOI: 10.3390/jpm14111100.


Pulsed Electromagnetic Fields (PEMFs) Trigger Cell Death and Senescence in Cancer Cells.

Pantelis P, Theocharous G, Veroutis D, Vagena I, Polyzou A, Thanos D Int J Mol Sci. 2024; 25(5).

PMID: 38473720 PMC: 10931548. DOI: 10.3390/ijms25052473.


Surgical coronary angioplasty of both coronary ostia after chest radiotherapy. Is it good alternative to conventional coronary bypass surgery?.

Mamedov A, Rumbinaite E, Karciauskas D, Jakuskaite G, Veikutiene A, Jakuska P Perfusion. 2023; 40(1):247-250.

PMID: 38066688 PMC: 11715061. DOI: 10.1177/02676591231221707.


Forty years after mediastinal radiotherapy for Hodgkin lymphoma: how late is late cardiotoxicity? A case report.

Ha F, McLellan A, Newcomb A, Creati L Eur Heart J Case Rep. 2023; 7(7):ytad288.

PMID: 37416512 PMC: 10320229. DOI: 10.1093/ehjcr/ytad288.


References
1.
Desai M, Jellis C, Kotecha R, Johnston D, Griffin B . Radiation-Associated Cardiac Disease: A Practical Approach to Diagnosis and Management. JACC Cardiovasc Imaging. 2018; 11(8):1132-1149. DOI: 10.1016/j.jcmg.2018.04.028. View

2.
Seemann I, Gabriels K, Visser N, Hoving S, te Poele J, Pol J . Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol. 2011; 103(2):143-50. DOI: 10.1016/j.radonc.2011.10.011. View

3.
Boyle J, Ackerson B, Gu L, Kelsey C . Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer. Adv Radiat Oncol. 2017; 2(1):6-11. PMC: 5514227. DOI: 10.1016/j.adro.2016.12.006. View

4.
Stoltzfus K, Zhang Y, Sturgeon K, Sinoway L, Trifiletti D, Chinchilli V . Fatal heart disease among cancer patients. Nat Commun. 2020; 11(1):2011. PMC: 7181822. DOI: 10.1038/s41467-020-15639-5. View

5.
van Nimwegen F, Schaapveld M, Janus C, Krol A, Petersen E, Raemaekers J . Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk. JAMA Intern Med. 2015; 175(6):1007-17. DOI: 10.1001/jamainternmed.2015.1180. View